Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumason Bolus vs Continuous Infusion in Suboptimal Echocardiography
NCT06400004Phase 3Recruiting
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Jul 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfur hexafluoride, sponsored by Bracco Diagnostics Inc.. Started Jul 2024; status: recruiting.
02
Drugs
sulfur hexafluoride
Beyond the preview
Go deeper on NCT06400004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06400004.